Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Moderna

Novavax

Pfizer

Check out these health care stocks that are heating up in the stock market right now.

4 Top Health Care Stocks To Watch In The Stock Market Today

Walgreens

Walmart

Jurors in Cleveland federal court have determined that pharmacy chain operators CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance Inc (NASDAQ: WBA), and Walmart Inc (NYSE: WMT) helped fuel the opioid epidemic in two counties in Ohio, Reuters reports. The jurors concluded that the companies helped create a public nuisance through an abundant supply of pain killers and diversion of those drugs to the black market.

US Jury Finds Pharmacy Chains Did Not Monitor Opioid Usage, Thus Fueling Epidemic: Reuters

Agree Realty

Alexander & Baldwin

Federal Realty Investment Trust

Kimco Realty

NETSTREIT Corp

New York City REIT Inc

Realty Income Corp

Regency Centers

Spirit Realty Capital

CVS Health Corp. to close nearly 10% of its US locations over the next three years. In an agenda to improve profitability, the company plans to add new health services.

CVS To Close 900 Stores: Smart Move And REIT Landlords Benefit Too

CVS Health's (CVS) time-delay safes reduce theft and diversion of opioid medications and boost the security of stores, creating a safe environment for patients and staff.

CVS Health (CVS) Installs Time-Delay Safes in Texas Pharmacies

AstraZeneca

Bristol-Myers

Novartis

Patterson Companies

Needless to say, 2021 has been a banner year for equities, with the S&P 500 up a stunning 25%.

Top Strategist Says Health Care Could Rule in 2022: 5 Dividend Winners

CVS Group (AIM:CVSG) PLC, the chain of veterinary surgeries, reported continued strong growth for the first four months of its financial years. Like-for-like sales were up 12.4% for the four months to 31 October, with total sales up 13.8% compared to the same period last year.

CVS Group sales and margins continue to climb

Stocks of drugmakers and pharmacies facing litigation over the opioid crisis were stable after two Ohio counties successfully sued CVS Health, Walgreens, and Walmart in U.S. District Court. The companies are expected to appeal.

Jury Finds Pharmacy Chains Contributed to Opioid Crisis

A federal jury said CVS, Walgreens and Walmart helped fuel the opioid abuse crisis in two Ohio counties, the first verdict in a lawsuit of its kind.

CVS, Walgreens, Walmart Found Liable For Distributing Painkillers

A federal jury on Tuesday found that pharmacy chain operators CVS, Walgreens Boots Alliance and Walmart helped fuel an opioid epidemic in two Ohio counties, in the first trial the companies have faced over the US drug crisis. Jurors in Cleveland federal court concluded that actions by the pharmacy chains helped create a public nuisance that resulted.

CVS, other pharmacy chains lose Ohio suit in first opioid epidemic trial

The opioid crisis has killed a half-million Americans over the past two decades. The jury's verdict could impact pharmacy accountability.

CVS, Walgreens, and Walmart helped fuel the opioid crisis, jury finds

WOONSOCKET, R.I., Nov. 23, 2021 /PRNewswire/ -- As part of an ongoing commitment to helping build healthier and safer communities, CVS Health (NYSE: CVS) today announced the completed installation of time delay safe technology in all 851 CVS Pharmacy locations, including those in Target stores, across Texas.

CVS Health Completes Rollout of Time Delay Safes in All 851 Texas Pharmacies

ARK Innovation ETF

Tuttle Capital Short Innovation ETF

And even if you aren't worried about the markets, these are prudent things to consider to minimize your overall risk.

Worried About a Market Crash? Here Are 3 Things You Can Do

Blackstone Group

Extra Space Storage

Freeport-McMoRan

Gilead Sciences

All the Wall Street firms that we follow here at 24/7 Wall St. keep a list for their institutional and retail clients of high-conviction stock picks.

5 Jefferies Franchise Picks Pay Solid Dividends and Can Whip Inflation Now

The stock price of CVS Health rose 3% yesterday after the company announced that it will close 900 of its stores, reflecting 9% of its total stores in the U.S. The company will focus on adding primary care offerings at some of its existing stores, and maintain traditional stores that offer.

What's Happening With CVS Health Stock?

At a time when so many people are reliant on pharmacies, this reads like a surprise move.

What CVS' Major Store Closures Mean for Retail

CVS' announcement Thursday that it will close 900 stores over the next three years — around 10% of its pharmacies — may have caught some shoppers off guard.

CVS had every advantage, but it lost the pandemic. Here's what happened

The decision by pharmacy giant CVS to shutter 900 stores over the next three years as part of a pivot to a more omnichannel healthcare approach is a sign of changing dynamics in the sector. In addition to a shuffling of the C-suite — Prem Shah and Michelle Peluso take over as co-presidents of CVS Health's […]

CVS, Walmart Take Lead on Omnichannel Healthcare Superstores for Post-Pandemic Era

CVS will be closing 900 of its physical stores over the next three years while revamping some of its stores to better cater to the local community's needs.

CVS Health: Not Expensive For What It's Worth

CVS Health's (CVS) new measures will support its strategy of making health care more affordable, accessible and convenient for consumers.

CVS Health's (CVS) New Measures to Boost Omnichannel Health

CVS is heading in the wrong direction: Traditional pharmacies are on the decline, and America's largest drug store chain plans to close about one in 10 of its outdated locations. One company is particularly primed to take advantage — and it's not Walgreens or Rite Aid.

The discount store wants to be more like a pharmacy. CVS closing 900 stores will help

Heritage-Crystal Clean

HeadHunter Group PLC - ADR

Phillips 66

HHR, CVS, PSX, and HCCI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 19, 2021.

Best Growth Stocks to Buy for November 19th

Macy's

CVS will close about 900 stores over the next three years, and Macy's has added ten more stores to its list of 125 to close by 2023. However, the closure announcements have made it difficult to see the bigger picture; retail vacancies are at their lowest.

Why CVS And Macy's Are Closing Stores When Demand For Retail Real Estate Is Rising

The shares of CVS Health Corp (NYSE:CVS) are up 2.9% this afternoon, following the pharmacy company's decision to shutter 900 of its stores within the next three years -- beginning spring of 2022.

CVS Stock Keeps Climbing During Store Closure Update Test2

Cushman & Wakefield plc

Ventas

Subleasing office space past its peak, while CVS plans 900 store closings.

Top Real Estate News for Thursday, Nov. 18, 2021: Office Space Subleasing Declines

Retail, pharmacy and healthcare company CVS Health Corp. on Thursday (Nov. 18) announced that it's adding primary care offices at some of its locations and converting other stores into health hubs with diagnostic testing, mental health services and hearing exams, according to The Wall Street Journal. The plan comes as the company announced it's closing […]

News for CVS Health Stock (CVS)